Medicenna Therapeutics News

Medicenna Therapeutics | D: Filing D

May 14, 2024 15:45 ET

Medicenna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.

May 10, 2024 17:54 ET

Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fahar Merchant(29.1%),Rosemina Merchant(29.1%), etc.

Feb 21, 2024 20:32 ET

Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Orin H(6.7%),AIGH Capital Management, LLC(6.6%)

Feb 7, 2024 18:57 ET

Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Orin H(6.4%),AIGH Capital Management, LLC(6.2%)

Feb 15, 2023 06:35 ET

Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fahar Merchant(25.7%),Rosemina Merchant(25.7%), etc.

Feb 14, 2023 14:30 ET

Medicenna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Orin H(5.6%),AIGH Capital Management, LLC(5.5%)

Oct 20, 2022 06:02 ET

Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fahar Merchant(31.5%),Rosemina Merchant(31.5%), etc.

Feb 10, 2022 14:48 ET

Medicenna Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 12, 2021 16:24 ET

Medicenna Therapeutics | D/A: Filing D (Amendment)

Apr 20, 2020 14:25 ET

Medicenna Therapeutics | D: Filing D

Mar 30, 2020 12:38 ET